|
Oligonucleotides |
|
Enduring |
|
$25.00 |
|
Immuno-oncology |
|
Enduring |
|
$25.00 |
|
Immuno-oncology |
|
Enduring |
|
$25.00 |
|
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Immunophenotyping |
|
Enduring |
|
$25.00 |
|
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Systems biology applied to immune safety |
|
Enduring |
|
$25.00 |
|
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Immunogenicity characterization tools (ADAs, complement, immune complexes) |
|
Enduring |
|
$25.00 |
|
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
|
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
Facebook
Twitter
LinkedIn
Forward